STAT1 modification improves therapeutic effects of interferons on lung cancer cells-Reference-Cited by-同舟云学术

STAT1 modification improves therapeutic effects of interferons on lung cancer cells

Published:2015-09-08 Issue:1 Volume:13 Page:
ISSN:1479-5876
Container-title:Journal of Translational Medicine
language:en
Short-container-title:J Transl Med

Author:

Chen Junjie,Zhao Jialu,Chen Lefu,Dong Nian,Ying Zhaojian,Cai Zhenzhen,Ji Dongxiang,Zhang Yong,Dong Li,Li Yuping,Jiang Lei,Holtzman Michael J.,Chen Chengshui

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12967-015-0656-0

Reference42 articles.

1. Field JK, Duffy SW. Lung cancer screening: the way forward. Br J Cancer. 2008;99(4):557–62. doi: 10.1038/sj.bjc.6604509 .

2. Yang P, Allen MS, Aubry MC, Wampfler JA, Marks RS, Edell ES, et al. Clinical features of 5,628 primary lung cancer patients: experience at Mayo Clinic from 1997 to 2003. Chest. 2005;128(1):452–62. doi: 10.1378/chest.128.1.452 .

3. Wilderman MJ, Sun J, Jassar AS, Kapoor V, Khan M, Vachani A, et al. Intrapulmonary IFN-beta gene therapy using an adenoviral vector is highly effective in a murine orthotopic model of bronchogenic adenocarcinoma of the lung. Cancer Res. 2005;65(18):8379–87. doi: 10.1158/0008-5472.CAN-05-0920 .

4. Trinchieri G. Type I interferon: friend or foe? J Exp Med. 2010;207(10):2053–63. doi: 10.1084/jem.20101664 .

5. Mizokami MM, Hu P, Khawli LA, Li J, Epstein AL. Chimeric TNT-3 antibody/murine interferon-gamma fusion protein for the immunotherapy of solid malignancies. Hybrid Hybridomics. 2003;22(4):197–207. doi: 10.1089/153685903322328929 .

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. STAT1 mediated downregulation of the tumor suppressor gene PDCD4, is driven by the atypical cadherin FAT1, in glioblastoma;Cellular Signalling;2024-07

2. STAT1-Deficient HPV E6/E7-Associated Cancers Maintain Host Immunocompetency against Therapeutic Intervention;Vaccines;2024-04-17

3. The atypical cadherin FAT1 is a novel regulator of STAT1, driving its pro-tumorigenic effect via the STAT1/PDCD4 axis in glioblastoma;2023-09-23

4. The potential roles of JAK/STAT signaling in the progression of osteoarthritis;Frontiers in Endocrinology;2022-11-24

5. Expression of STAT family and its potency to prognosis in uterine corpus endometrial carcinoma;2022-11-17